Image segmentation improves quantitative spatial biology analysis by enabling precise, cell-by-cell measurement of protein expression, morphology, and spatial relationships within tissue sections. Without accurate segmentation, signal from neighboring cells bleeds together, making it impossible to assign molecular data to individual cells. The sections below address the most common questions researchers have about segmentation in spatial omics workflows.
What types of errors occur without accurate image segmentation?
Without accurate image segmentation, quantitative spatial biology data suffers from signal misattribution, boundary overlap, and false co-localization. These errors propagate through downstream analysis, producing unreliable cell counts, distorted expression profiles, and spatial relationships that do not reflect the biology of the tissue being studied.
The most common error is cell merging, where two adjacent cells are treated as a single unit. This artificially inflates measured signal intensity and masks heterogeneity between neighboring cell populations. In densely packed tissue sections, such as tumor cores or lymphoid structures, merging can affect a substantial proportion of detected objects.
A second frequent problem is signal spillover. When cell boundaries are poorly defined, fluorescence or transcript counts from one cell are assigned to an adjacent cell. In multiplex imaging panels with many markers, this spillover compounds across channels and distorts co-expression analysis.
Other errors that arise from poor segmentation include:
- Fragmented cells counted as multiple objects, inflating cell numbers
- Loss of rare cell types that are smaller than the segmentation threshold
- Incorrect spatial neighborhood calculations, affecting cell-cell interaction mapping
- Reduced reproducibility across tissue sections and experimental replicates
For researchers in Benelux pharmaceutical and biotech laboratories working with multiplex imaging or spatial omics platforms, these errors directly affect the biological conclusions drawn from tissue imaging data, making segmentation accuracy a foundational quality concern.
How does image segmentation define cell boundaries in tissue sections?
Image segmentation defines cell boundaries in tissue sections by identifying regions of the image that correspond to individual cells, separating them from surrounding tissue, background, and adjacent cells. The process relies on contrast between cellular compartments and the surrounding space, using signal intensity gradients to draw boundaries at the cell level.
In practice, segmentation algorithms analyze one or more reference channels, typically a nuclear stain such as DAPI or a membrane marker, to locate each cell’s position within the tissue. Once a reference signal is identified, the algorithm expands outward from that seed point to estimate the full cell boundary, stopping where signal intensity drops or where a neighboring cell’s signal begins.
The accuracy of boundary definition depends on several factors: the quality of the staining protocol, the resolution of the imaging system, the density of cells in the tissue, and the segmentation strategy used. In tissues where cells are well separated, boundary definition is relatively straightforward. In complex tissue architectures with tightly packed cells or overlapping processes, the algorithm must make probabilistic decisions about where one cell ends and another begins.
Modern segmentation approaches also incorporate contextual information from multiple channels simultaneously. Rather than relying on a single marker, multi-channel segmentation uses complementary signals from nuclear, cytoplasmic, and membrane stains to refine boundary placement, reducing errors in regions where a single-channel approach would fail.
What’s the difference between nucleus-based and membrane-based segmentation?
Nucleus-based segmentation identifies cells by detecting and expanding from the nuclear signal, while membrane-based segmentation uses a cell membrane marker to draw boundaries directly at the cell surface. The key difference is where the boundary originates: nucleus-based methods estimate the cell edge by expansion, whereas membrane-based methods detect it directly.
Nucleus-based segmentation
Nucleus-based cell segmentation is the most widely used approach in tissue imaging because nuclear stains such as DAPI are robust, bright, and compatible with virtually every multiplex imaging workflow. The algorithm detects each nucleus, then applies an expansion radius or a watershed transform to estimate where the cytoplasm and cell membrane are likely to be. This approach works well in tissues where cells are moderately spaced, but the expansion step introduces uncertainty in densely packed regions because the true cell boundary is inferred rather than measured.
Membrane-based segmentation
Membrane-based segmentation uses a dedicated membrane marker, such as E-cadherin in epithelial tissue or CD45 in immune cell populations, to trace cell outlines directly. This approach provides more accurate boundary placement in dense tissues and is particularly valuable when cytoplasmic compartments need to be measured independently from the nucleus. The limitation is that membrane markers are cell-type specific, meaning a single marker may not label all cells in a heterogeneous tissue section equally well.
In practice, many spatial biology workflows combine both approaches, using nuclear signal for cell detection and membrane signal for boundary refinement. This hybrid strategy captures the robustness of nucleus-based detection while improving the spatial accuracy of membrane-based delineation.
How does AI-based segmentation outperform traditional thresholding methods?
AI-based segmentation outperforms traditional thresholding methods by learning contextual features of cell morphology rather than applying a fixed intensity cutoff. Thresholding treats every pixel above a set value as foreground, which fails when staining intensity varies across a tissue section. AI models adapt to local context, correctly identifying cells even when signal is uneven or background is complex.
Traditional global thresholding assigns pixels to foreground or background based on a single intensity value. This works reasonably well in uniform samples but breaks down in tissue sections where staining intensity varies due to antibody penetration depth, tissue thickness, or fixation differences. Cells in low-signal regions are missed entirely, while high-background areas generate false detections.
Deep learning-based segmentation models, trained on large annotated image datasets, recognize cells by their shape, texture, and relationship to surrounding structures rather than by intensity alone. These models can distinguish touching cells that a threshold algorithm would merge, detect cells at the edge of tissue folds, and correctly segment irregular cell morphologies that would confuse rule-based approaches.
For researchers running cellular analysis workflows on complex tissue types, AI-based segmentation also reduces the need for manual parameter adjustment between tissue types and staining batches. Once trained, a well-validated model generalizes across tissue sections with minimal user intervention, improving both throughput and reproducibility in quantitative spatial biology pipelines.
Which spatial biology platforms integrate segmentation into their analysis pipelines?
Most contemporary spatial biology platforms integrate image segmentation directly into their analysis pipelines, treating it as a core step between image acquisition and quantitative data extraction. This integration means that segmentation is no longer a separate manual task but is embedded in the workflow from tissue image to single-cell expression matrix.
Platforms designed for multiplex imaging, spatial transcriptomics, and spatial proteomics each handle segmentation differently depending on the type of data they generate. In multiplex imaging systems, segmentation is applied to fluorescence images to define cell boundaries before marker intensities are extracted per cell. In spatial transcriptomics workflows, segmentation is used to assign transcript counts to individual cells rather than to spatial bins, improving the resolution of gene expression data.
Analysis software associated with these platforms typically offers multiple segmentation options, including nuclear expansion, membrane-based boundary detection, and AI-driven cell identification. Many platforms now allow researchers to import custom segmentation models trained on their specific tissue types, giving laboratories the flexibility to optimize segmentation for their particular biological context.
Regardless of platform, the quality of integrated segmentation determines the quality of all downstream spatial omics data. Researchers evaluating spatial biology instruments should assess not only image resolution and panel size but also the robustness and flexibility of the segmentation tools included in the analysis pipeline.
When should manual segmentation review still be part of the workflow?
Manual segmentation review should remain part of the workflow whenever automated methods encounter tissue regions or cell types that fall outside the conditions the algorithm was optimized for. Fully automated segmentation is reliable for well-stained, morphologically typical cells, but specific scenarios consistently benefit from human review to protect data quality.
The following situations call for manual review as a standard quality control step:
- Novel tissue types: When a segmentation model has not been validated on the specific tissue being analyzed, manual inspection of a representative subset confirms whether boundary placement is biologically accurate.
- Rare cell populations: Small or morphologically atypical cells, such as circulating tumor cells within a tissue section or small lymphocytes adjacent to large stromal cells, are frequently under-segmented or merged by automated algorithms.
- Tissue artifacts: Folds, tears, and areas of poor staining quality generate segmentation errors that automated quality filters may not catch. Manual review identifies these regions so they can be excluded from quantitative analysis.
- High-stakes datasets: In experiments where results will inform a significant research decision or publication, manual review of a randomly sampled subset provides an independent validation of automated output.
- Algorithm training and validation: When building or refining a deep learning segmentation model, annotated manual segmentations serve as ground truth, making expert review an essential part of the model development cycle.
Manual review does not need to cover every cell in every image. A structured sampling strategy, reviewing defined regions of interest or a fixed percentage of cells per section, provides meaningful quality assurance without making the workflow impractical at scale.
How BioSPX supports spatial biology imaging and analysis
BioSPX supports researchers in Belgium, the Netherlands, and Luxembourg who are building or expanding spatial biology workflows. The portfolio includes imaging and microscopy systems, multimode readers, and liquid handling solutions suited to multiplex tissue imaging and quantitative image analysis applications.
BioSPX provides:
- Expert advice from product specialists on instrument selection and experimental configuration
- Installation, user training, and ongoing technical support
- Pre- and post-sales guidance to help laboratories match instruments to their specific tissue imaging and segmentation requirements
- Access to innovative solutions for cell analysis and laboratory automation in the Benelux region
If you are evaluating imaging platforms for spatial omics research or need guidance on integrating image segmentation into your analysis pipeline, contact the BioSPX team to discuss your requirements with a specialist.
Frequently Asked Questions
How do I know if my current segmentation settings are good enough for my tissue type?
The most reliable way to evaluate segmentation quality is to visually overlay the segmentation masks onto the raw image and inspect boundary placement across multiple tissue regions, including dense areas, tissue edges, and zones with low staining intensity. Key red flags include merged neighboring cells, fragmented single cells, and boundaries that consistently miss cytoplasmic signal. Running a quantitative check — such as comparing cell size distributions and marker intensity profiles against expected biological values for your tissue type — adds an objective layer of validation on top of visual inspection.
Can I use the same segmentation model across different tissue types in the same study?
Using a single model across different tissue types in the same study is possible but carries risk, since cell morphology, density, and staining characteristics can vary substantially between tissue compartments. A model trained or validated on one tissue type may systematically under-segment or over-expand cells in another. The safest approach is to validate model performance on a representative subset of each tissue type included in the study before applying it to the full dataset, and to retrain or fine-tune the model if accuracy is insufficient for any tissue in the cohort.
What should I do when automated segmentation consistently misses small or rare cell types?
When automated segmentation underperforms on rare or small cell populations, the first step is to check whether the expansion radius or minimum cell size threshold is excluding these cells by design. Adjusting size parameters or switching to a membrane-based approach for those specific cell types can recover missed detections. If parameter tuning is insufficient, creating a small manually annotated training set of the problematic cell type and fine-tuning a deep learning model on it is the most robust long-term solution, particularly for cell types that are critical to your biological question.
How does poor segmentation specifically affect spatial neighborhood and cell-cell interaction analysis?
Spatial neighborhood analysis calculates which cells are adjacent to one another and uses those relationships to infer cell-cell interactions, niche compositions, and tissue organization. When segmentation is inaccurate, cell centroids and boundaries are misplaced, causing the algorithm to assign incorrect neighbors — for example, treating two merged cells as a single large cell that appears to interact with more neighbors than it actually does. These errors compound in downstream analyses such as ligand-receptor interaction scoring or cellular niche clustering, potentially generating interaction signals that reflect segmentation artifacts rather than true tissue biology.
Is there a minimum image resolution required for accurate cell segmentation in multiplex tissue imaging?
While there is no universal minimum that applies to every tissue type, a general guideline is that the imaging resolution should be sufficient to resolve individual cell nuclei as distinct objects, which typically means a pixel size of 0.5 µm or smaller for standard tissue sections imaged at 20× or higher magnification. At lower resolutions, small cells become indistinguishable from background noise and touching cells cannot be separated reliably by any segmentation algorithm. If your imaging system operates at lower magnification for throughput reasons, validating segmentation accuracy on a higher-resolution reference image of the same tissue is a useful quality control step.
What is the best way to handle segmentation in tissue sections with significant staining variability between batches?
Staining variability between batches is one of the most common sources of segmentation inconsistency in multi-slide studies, and addressing it requires action at both the staining and analysis stages. On the staining side, standardizing antibody concentrations, fixation times, and antigen retrieval conditions reduces batch-to-batch variation before it reaches the segmentation step. On the analysis side, using an AI-based segmentation model rather than fixed-threshold methods provides greater robustness to intensity differences, and applying image normalization or contrast enhancement as a preprocessing step before segmentation can further reduce the impact of batch effects on boundary detection.
At what point in a new spatial biology project should segmentation strategy be decided?
Segmentation strategy should be decided during experimental design, before staining panels are finalized, not after images have already been acquired. The choice between nucleus-based, membrane-based, or hybrid segmentation directly determines which reference markers need to be included in the imaging panel — for example, a membrane-based approach requires a suitable pan-membrane or cell-type-specific membrane marker to be reserved in the panel. Deciding on segmentation strategy late in the process often forces researchers to work with suboptimal reference channels, limiting the accuracy that can be achieved regardless of which algorithm is applied.
Related Articles
- How can researchers combine tissue mapping with molecular interaction measurements?
- What is the difference between intrinsic and acquired drug resistance in cancer?
- How can flow cytometry complement live-cell imaging in treatment response studies?
- Can lifestyle changes actually reduce cancer risk?
- How does cancer affect the immune system?
This content was generated with the help of AI and it may contain mistakes